Crestline Investors, Inc., 10% Owner at Denali Therapeutics Inc. (DNLI), sold 3,894,764 shares at $20.25 ($78.9M) on 2020-02-26, disclosed to the SEC on 2020-02-28.
Open-market sale of $78.9M DNLI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| JUNO | SELL | 2016-03-03 | $335.4M | — | Filing → |